Fusobacterium nucleatum T18 aggregates human mononuclear cells and inhibits their PHA-stimulated proliferation - PubMed (original) (raw)
Fusobacterium nucleatum T18 aggregates human mononuclear cells and inhibits their PHA-stimulated proliferation
S Kinder Haake et al. J Periodontol. 1997 Jan.
Abstract
In previous studies Fusobacterium nucleatum has been shown to induce either stimulatory or inhibitory effects on human mononuclear cells. We examined the interaction of human mononuclear cells with human and cynomolgus monkey strains of F. nucleatum. Peripheral blood mononuclear cells (PBMCs) isolated from normal donors were aggregated in the presence of cells of F. nucleatum but not control bacteria. The aggregation of PBMCs and F. nucleatum T18 was inhibited by either L-arginine, L-lysine, or pretreatment of the bacterial cells with heat, but was unaffected by the presence of sugars or normal human serum. Strain T18 aggregated purified T-cells and monocytes at approximately equal concentrations. When F. nucleatum T18 was incubated with PHA-stimulated PBMCs, DNA synthesis in the PBMCs was significantly inhibited and detection of IL-2R alpha on the PBMCs was reduced. These studies indicate that F. nucleatum aggregates PBMCs, and that this interaction is associated with both an inhibition of PBMC proliferation and a decrease in IL-2 receptor expression. The ability of F. nucleatum to inhibit mononuclear cell proliferation may be significant in the pathogenesis of periodontal diseases.
Similar articles
- The role of aggregation in Fusobacterium nucleatum- induced immune cell death.
Huynh T, Kapur RV, Kaplan CW, Cacalano N, Kinder Haake S, Shi W, Sieling P, Jewett A. Huynh T, et al. J Endod. 2011 Nov;37(11):1531-5. doi: 10.1016/j.joen.2011.06.034. Epub 2011 Sep 3. J Endod. 2011. PMID: 22000457 - Antiproliferative activity of Actinobacillus (Haemophilus) actinomycetemcomitans and Fusobacterium nucleatum in peripheral blood mononuclear cells.
do Vale CH, de Oliveira Fraga LA, Costa AS, Tavares CA, Martins-Filho OA, de Macedo Farias L, Roque de Carvalho MA. do Vale CH, et al. Res Microbiol. 2004 Nov;155(9):731-40. doi: 10.1016/j.resmic.2004.05.008. Res Microbiol. 2004. PMID: 15501650 - Effect of whole oral bacteria and extracted lipopolysaccharides on peripheral blood leukocyte interleukin-2 receptor expression.
Lindemann RA, Kjeldsen M, Cabret M. Lindemann RA, et al. J Periodontal Res. 1995 Jul;30(4):264-71. doi: 10.1111/j.1600-0765.1995.tb02132.x. J Periodontal Res. 1995. PMID: 7562323 - Fusobacterium nucleatum: an emerging gut pathogen?
Allen-Vercoe E, Strauss J, Chadee K. Allen-Vercoe E, et al. Gut Microbes. 2011 Sep 1;2(5):294-8. doi: 10.4161/gmic.2.5.18603. Epub 2011 Sep 1. Gut Microbes. 2011. PMID: 22067936 Review. - Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
Bashir A, Miskeen AY, Hazari YM, Asrafuzzaman S, Fazili KM. Bashir A, et al. Tumour Biol. 2016 Mar;37(3):2805-10. doi: 10.1007/s13277-015-4724-0. Epub 2015 Dec 30. Tumour Biol. 2016. PMID: 26718210 Review.
Cited by
- Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells.
Edwards AM, Grossman TJ, Rudney JD. Edwards AM, et al. Infect Immun. 2006 Jan;74(1):654-62. doi: 10.1128/IAI.74.1.654-662.2006. Infect Immun. 2006. PMID: 16369022 Free PMC article. - Low Abundance Fusobacterium Nucleatum Supports Early Pregnancy Development - An In Vitro Study.
Heusler M, Einenkel R, Ehrhardt J, Muzzio DO, Zygmunt M. Heusler M, et al. Front Immunol. 2021 Aug 31;12:698045. doi: 10.3389/fimmu.2021.698045. eCollection 2021. Front Immunol. 2021. PMID: 34531854 Free PMC article. - Persistent Exposure to Fusobacterium nucleatum Triggers Chemokine/Cytokine Release and Inhibits the Proliferation and Osteogenic Differentiation Capabilities of Human Gingiva-Derived Mesenchymal Stem Cells.
Kang W, Ji X, Zhang X, Tang D, Feng Q. Kang W, et al. Front Cell Infect Microbiol. 2019 Dec 17;9:429. doi: 10.3389/fcimb.2019.00429. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31921705 Free PMC article. - Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K, Sukawa Y, Adachi Y, Ito M, Mitsuhashi K, Kurihara H, Kanno S, Yamamoto I, Ishigami K, Igarashi H, Maruyama R, Imai K, Yamamoto H, Shinomura Y. Nosho K, et al. World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557. World J Gastroenterol. 2016. PMID: 26811607 Free PMC article. Review. - Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms.
Fan Z, Tang P, Li C, Yang Q, Xu Y, Su C, Li L. Fan Z, et al. J Oral Microbiol. 2022 Nov 14;15(1):2145729. doi: 10.1080/20002297.2022.2145729. eCollection 2023. J Oral Microbiol. 2022. PMID: 36407281 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources